Do CoQ10, riboflavin B2, and niacin B3 reflect mitochondrial oxidative phosphorylation strain?

Mitochondrial oxidative phosphorylation (OXPHOS) relies on a continuous, highly coordinated flux of electrons to generate cellular ATP. Coenzyme Q10 (CoQ10), riboflavin (vitamin B2), and niacin (vitamin B3) serve as the fundamental redox machinery enabling this energy transfer.

Biochemical mechanisms of redox transfer

• Niacin (B3) is the direct precursor to nicotinamide adenine dinucleotide (NADH/NAD+), which acts as the primary two-electron hydride donor initiating the electron transport chain (ETC) at Complex I.
• Riboflavin (B2) is synthesized into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). FMN converts two-electron transfers from NADH into single-electron steps within Complex I, while FAD mediates the oxidation of succinate to fumarate at Complex II.
• CoQ10 serves as the central, mobile, lipid-soluble electron carrier. It cycles between ubiquinone, semiquinone, and ubiquinol states to shuttle electrons from both Complexes I and II to Complex III via the Q-cycle, driving the proton gradient necessary for ATP generation.

Biomarkers of oxidative phosphorylation strain

• Organic acid accumulation: When the metabolic demand for these cofactors exceeds supply, electron transport stalls. This bioenergetic bottleneck causes the accumulation of characteristic organic acids; specifically, elevations in glutarate and ethylmalonate signal flavoprotein dysfunction, while elevated succinate and fumarate point to depletion of CoQ10, riboflavin, or NAD+.
• Metabolic stress signaling: Elevated levels of growth differentiation factor 15 (GDF15) in saliva or plasma serve as a sensitive, non-invasive biomarker indicating mitochondrial DNA mutations, OXPHOS defects, and systemic metabolic strain.

Bottom line

• CoQ10, riboflavin, and niacin are indispensable redox cofactors; an increased functional need for these nutrients—evidenced by elevated organic acids or GDF15—directly indicates underlying strain in mitochondrial oxidative phosphorylation and impaired ATP synthesis.